Related Experiment Videos

[Treatment of bone and soft tissue sarcomas]

J Rouëssé¹, M Tubiana-Hulin

¹Centre René Huguenin, Saint-Cloud.

Presse Medicale (Paris, France : 1983)

|August 7, 1991

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis.

British journal of cancer·2010

Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group.

Annals of oncology : official journal of the European Society for Medical Oncology·2008

Practical guidance for the management of aromatase inhibitor-associated bone loss.

Annals of oncology : official journal of the European Society for Medical Oncology·2008

Phase II multicenter study of larotaxel (XRP9881), a novel taxoid, in patients with metastatic breast cancer who previously received taxane-based therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2008

Oligonucleotide microarray analysis of estrogen receptor alpha-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen.

Journal of molecular endocrinology·2007

Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution.

Annals of oncology : official journal of the European Society for Medical Oncology·2006

See all related articles